Harrington Investments’s Biogen BIIB Stock Holding History

Harrington Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,310	Closed	-$540K	–	81
2019 Q2	$540K	Buy	+2,310	New	+$533K	0.44%	58

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Harrington Investments's BIIB Position: Q3 2019 in Review

Harrington Investments sold out of Biogen (BIIB) in Q3 2019, closing a stake of 2,310 shares — an estimated $540K sold.

Harrington Investments first reported a position in BIIB in Q2 2019 and held it in 1 quarter. The position peaked at $540K in Q2 2019. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Harrington Investments reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Harrington Investments sold 2,310 Biogen shares in Q3 2019, an estimated $540K.
Harrington Investments first reported a position in Biogen in Q2 2019 and held it in 1 quarter.
Harrington Investments's Biogen position peaked at $540K in Q2 2019.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Harrington Investments's 13F filing for Q3 2019, filed 5 Nov 2019.